← FDA Drug Approvals (Drugs@FDA)
FLUDEOXYGLUCOSE F18
NDA · New Drug Application · Sponsor: WEILL MEDCL COLL · Approved 2004-08-05
Drug application
- FDA Application #
NDA021768- Application type
- New Drug Application
- Brand name
- FLUDEOXYGLUCOSE F18
- Generic name
- Fludeoxyglucose F-18
- Active ingredients
- FLUDEOXYGLUCOSE F-18
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- WEILL MEDCL COLL
- First approval
- 2004-08-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown